menu
    • menu

    Company profile for MBrace Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MBrace specializes in developing novel cancer treatments based on the SPARTA technology, a robust antibody discovery methodology pioneered by the company's founders. The SPARTA technology addresses key challenges in antibody development, enabling the rapid translation of human antibodies into clinical applications. MBrace's focus includes the development of Antibody-Drug Conjugates (ADCs) targeting two innovative cancer targ...
    MBrace specializes in developing novel cancer treatments based on the SPARTA technology, a robust antibody discovery methodology pioneered by the company's founders. The SPARTA technology addresses key challenges in antibody development, enabling the rapid translation of human antibodies into clinical applications. MBrace's focus includes the development of Antibody-Drug Conjugates (ADCs) targeting two innovative cancer targets using human antibodies selected through the SPARTA methodology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MBrace TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4660 La Jolla Village Dr., Suite 950 San Diego, California 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mbracetrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mbrace-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MBrace Presents ADC Program Poster At 2024 ASCO Annual Meeting
    MBrace Presents ADC Program Poster At 2024 ASCO Annual Meeting

    31 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240531344853/en

    BUSINESSWIRE
    31 May 2024
    Share Share
    MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer
    MBrace Therapeutics Appoints Steve Alley as Chief Scientific Officer

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305821859/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    MBrace Announces Initiation of Patient Dosing in Ph 1 Trial Evaluating MBRC-101
    MBrace Announces Initiation of Patient Dosing in Ph 1 Trial Evaluating MBRC-101

    19 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231219616403/en

    BUSINESSWIRE
    19 Dec 2023
    Share Share
    MBrace Presents Data Demonstrating Potential of Antibody Drug Conjugate
    MBrace Presents Data Demonstrating Potential of Antibody Drug Conjugate

    07 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231207958242/en

    BUSINESSWIRE
    07 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search